MiR-675 Promotes the Growth of Hepatocellular Carcinoma Cells Through Cdc25A Pathway

  • Yu, Ya-Qun (Department of Hepatobiliary Surgery, the Affiliated Hospital of Guilin Medical College) ;
  • Weng, Jun (Department of Hepatobiliary Surgery, the Affiliated Hospital of Guilin Medical College) ;
  • Li, Shu-Qun (Department of Hepatobiliary Surgery, the Affiliated Hospital of Guilin Medical College) ;
  • Li, Bo (Department of Hepatobiliary Surgery, the Affiliated Hospital of Guilin Medical College) ;
  • Lv, Jun (Department of Hepatobiliary Surgery, the Affiliated Hospital of Guilin Medical College)
  • Published : 2016.08.01


Background: MicroRNAs (miRNAs) have fundamental roles in tumorigenesis. MiR-675 is upregulated in hepatocellular carcinoma(HCC) cells. However, the roles of miR-675 in hepatocellular carcinogenesis are still not fully elucidated. In this study, we focus on investigating the effect and mechanism of miR-675 in proliferation of HCC cells. Materials and Methods: The cell proliferation was measured by MTT assays after transfection with miR-675 inhibitor and miR-675 mimics in HCC cells. The expression level of miR-675 was detected by real-time quantitative reverse transcription polymerase chain reaction. Protein expression of Cdc25A was measured by western blotting analysis. Results: In MTT assays, overexpression of miR-675 promoted the proliferation of HCC cells(P<0.05. at 48 hours, P<0.01. at 72 hours) compared with the miR-675mimics control group. Downexpression of miR-675 inhibited the proliferation of HCC cells(P<0.05. at 48 hours, P<0.01. at 72 hours) compared with the miR-675inhibitor control group. In western blotting analysis, the expression level of Cdc25A was significantly increased (p<0.05) after treatment with miR-675 mimics. The expression level of Cdc25A was significantly decreased (p<0.05) after treatment with miR-675 inhibitor. Conclusions: Our results indicate that miR-675 promotes the proliferation in human hepatocellular carcinoma cells by associating with Cdc25A signaling pathway.


Supported by : Natural Science Foundation of Guangxi Province


  1. Berteaux N, Lottin S, Monte D, et al (2005). H19mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem, 280, 29625-36.
  2. Blomberg I,Hoffmann I(1999). Ectopic expression of Cdc25A accelerates the G1/S transition and leads to premature activation of cyclinE-and cyclin A-dependent kinases. Mol Cell Biol, 19, 6183-94.
  3. Busino L, Chiesa M, Draetta GF,et al (2004). Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis.Oncogene, 23, 2050-6.
  4. Chen H, Lin YW, Mao YQ, et al (2012). microRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins. Cancer Lett, 320, 40-47.
  5. de Oliveira PE, Zhang L, Wang Z, et al (2009). Hypoxiamediated regulation of Cdc25A phosphatase by p21 and miR-21. Cell Cycle, 8, 3157-64.
  6. El-Serag HB,Rudolph KL(2007). Hepatocellular carcinoma:epidemiology and molecular carcinogenesis. Gastroenterol, 132, 2557-76.
  7. Gao N,Flynn DC,Zhang Z,et al (2004). G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/ mTOR/p70S6K1 signaling in human ovarian cancer cells. Am J Physiol Cell Physiol, 287, 281-91.
  8. Garzon R, Fabbri M, Cimmino A,et al (2006). MicroRNA expression and function in cancer. Trends Mol Med, 12, 580-7.
  9. Harbour JW, Luo RX, Dei Santi A, et al (1999). Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell, 98, 859-69.
  10. Hernandez JM,Elahi A, Clark CW, et al (2013). miR-675 mediates downregulation of twist1 and Rb in AFP-secreting hepatocellular carcinoma. Ann Surg Oncol, 3, 625-35.
  11. Hoffmann I, Draetta G, Karsenti E (1994). Activation of the phosphatase activity of human Cdc25A by aCdk2-cyclinE dependent phosphorylation at the G1/S transition. EMBO J, 13, 4302-10.
  12. Huang N, Lin J, Ruan J, et al (2012). MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3. FEBS Lett, 586, 884-91.
  13. Jiang X, Xiang G, Wang Y, et al (2012). MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-${\beta}$ RII. Mol Cells, 33, 545-551.
  14. Jovanovic M, Hengartner MO (2006). miRNAs and apoptosis: RNAs to die for. Oncogene, 25, 6176-87.
  15. Kang T, Wei Y, Honaker Y, et al (2008). GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell, 13, 36-47.
  16. Kristjansdottir K, Rudolph J (2004). Cdc25 phosphatases and cancer. Chem Biol, 11, 1043-51.
  17. Li HY, Zhang Y,Cai JH,et al (2013). MicroRNA-451 inhibits growth of human colorectal carcinoma cells via downregulation of Pi3k/Akt Pathway. Asian Pac J Cancer Prev, 14, 3631-4.
  18. Li J, Ran C, Li E, et al (2008). Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Dev Cell, 14, 62-75.
  19. Lin J, Huang S, Wu S,et al (2011). MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma. Carcinogenesis, 32, 1641-7.
  20. Lin YM, Chung CL, Cheng YS (2009). Posttranscriptional regulation of CDC25A by BOLL is a conserved fertility mechanism essential for human spermatogenesis. J Clin Endocrinol Metab, 94, 2650-7.
  21. Molinari M, Mercurio C, Dominguez J, et al (2000). Human Cdc25A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep, 1, 71-79.
  22. Roy P, Dasgupta UB (2013). The microRNA has-miR-503 inhibits growth of K562 cell line. Blood Cells Mol Dis, 50, 271-2.
  23. Tripathi V,Shen Z, Chakraborty A,et al (2013). Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet, 9, 1003368.
  24. Tsang WP, Ng EK, Ng SS, et al (2010). Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis, 31, 350-8.
  25. Vigo E, Muller H, Prosperini E, et al (1999). CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol Cell Biol, 19, 6379-95.
  26. Wang L, Li B, Li L, et al (2013). MicroRNA-497 Suppresses Proliferation and Induces Apoptosis in Prostate Cancer Cells. Asian Pac J Cancer Prev, 14, 3499-502.
  27. Wang P,Zou F,Zhang X,et al (2009). microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res, 69, 8157-65.
  28. Xu G, Zhang Y, Wei J, et al (2013). MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase3.BMC Cancer, 13, 469.
  29. Yang X, Feng M, Jiang X, et al (2009). miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1activity through a feedback loop by targeting CDK6 and CDC25A. Genes Dev, 23, 2388-93.
  30. Zhang B, Pan X, Cobb GP, et al (2007). microRNAs as oncogenes and tumor suppressors. Dev Biol, 302, 1-12.